YBX1 and medulloblastoma: In the present study, we show, for the first time, that high YB-1 gene expression is associated with poor survival outcomes in MBSHH, MBGroup3 and MBGroup4 patients, providing evidence of a likely oncogenic function for the protein in medulloblastoma.